Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial-Reference-Cited by-同舟云学术

Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial

Published:2017-02-16 Issue:3 Volume:112 Page:224-235
ISSN:1678-8060
Container-title:Memórias do Instituto Oswaldo Cruz
language:
Short-container-title:Mem. Inst. Oswaldo Cruz

Author:

Rassi Jr Anis¹,Marin Neto José Antonio²,Rassi Anis¹

Affiliation:

1. Hospital do Coração Anis Rassi, Brasil

2. Universidade de São Paulo, Brasil

Publisher

FapUNIFESP (SciELO)

Subject

Microbiology (medical)

Link

http://www.scielo.br/pdf/mioc/v112n3/0074-0276-mioc-0074-02760160334.pdf

Reference78 articles.

1. Absence of evidence is not evidence of absence;Altman DG;BMJ,1995

2. Chagas disease: still many unsolved issues;Álvarez JM;Mediators Inflamm,2014

3. I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy;Andrade JP;Arq Bras Cardiol,2011

4. Reversibility of cardiac fibrosis in mice chronically infected with Trypanosoma cruzi, under specific chemotherapy;Andrade SG;Mem Inst Oswaldo Cruz,1991

5. Myocardial changes in acute Trypanosoma cruzi infection. Ultrastructural evidence of immune damage and the role of microangiopathy;Andrade ZA;Am J Pathol,1994

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chagas Disease: Epidemiology, Diagnosis, and Treatment;Current Cardiology Reports;2024-08-08

2. Chagas Disease in the Non-Endemic Area of Rome, Italy: Ten Years of Experience and a Brief Overview;Infectious Disease Reports;2024-07-24

3. Clinician Knowledge of Chagas Disease After an Educational Intervention;JAMA Network Open;2024-07-02

4. Exploring the Dimensions of Pre-Clinical Research: 3D Cultures as an Investigative Model of Cardiac Fibrosis in Chagas Disease;Biomedicines;2024-06-25

5. Chagas disease in immunocompromised patients;Clinical Microbiology Reviews;2024-06-13